Symbiotec Pharmalab IPO Day 4: Issue booked 5.31 times so far. Here's GMP, review, & other key details
The Symbiotec Pharmalab IPO has seen strong demand, with an overall subscription of 5.31 times by the end of the third day. The IPO is valued at ₹988 per sha...